Food and Drug Administration
Blood Products Advisory Committee
June 14, 2002
Open Public Hearing
Cover Letter from BioTime, Inc. regarding Hextend ® doc
Summary, BioTime, Inc. doc
Hextend®, Abbott Labs pdf
Letter from Dr. Aryeh Shander to Dr Linda Smallwood, MD, FDA regarding STORMACT doc
Letter from Dr. Aryeh Shander, MD, Society for the Advancement of Blood Management doc